Implantable blood pump

Abstract
A method for assisting blood circulation in a patient includes drawing a flow of blood from a patient's heart into a blood flow channel formed by a housing. The flow of blood is passed through a motor stator to a rotor disposed within the blood flow channel. The motor stator is arranged circumferentially around the blood flow channel. The rotor has permanent magnetic poles for magnetic levitation and rotation of the rotor. The motor stator is controlled to act as a radial bearing for magnetic levitation of the rotor and to rotate the rotor within the blood flow channel. The rotor is levitated within the blood flow channel in the direction of the rotor axis of rotation via passive magnetic interaction between the rotor and the motor stator. The flow of blood is output from the blood flow channel to the patient.
Description
FIELD

This description relates to implantable blood pumps.


BACKGROUND

Ventricular assist devices, known as VADs, are implantable blood pumps used for both short-term and long-term applications where a patient's heart is incapable of providing adequate circulation. For example, a patient suffering from heart failure may use a VAD while awaiting a heart transplant. In another example, a patient may use a VAD while recovering from heart surgery. Thus, a VAD can supplement a weak heart or can effectively replace the natural heart's function. VADs can be implanted in the patient's body and powered by an electrical power source outside the patient's body.


BRIEF SUMMARY

In one general aspect, an implantable blood pump includes a housing and a blood flow conduit. Within the housing, the blood pump includes a stator located about the blood flow conduit and a magnetically-levitated rotor.


In another general aspect, an implantable blood pump includes a housing defining an inlet opening and an outlet opening. Within the housing, a dividing wall defines a blood flow conduit extending between the inlet opening and the outlet opening of the housing. The blood pump has a rotary motor that includes a stator and a rotor. The stator is disposed within the housing circumferentially about the dividing wall such that the inner blood flow conduit extends through the stator.


In another general aspect, an implantable blood pump includes a puck-shaped housing having a first face defining an inlet opening, a peripheral sidewall, and a second face opposing the first face. The blood pump has an internal dividing wall defining an inner blood flow conduit extending between the inlet opening and an outlet opening of the housing. The puck-shaped housing has a thickness from the first face to the second face that is less than a width of the housing between opposing portions of the peripheral sidewall. The blood pump also has a motor having a stator and a rotor. The stator is disposed in the housing circumferentially about the blood flow conduit and includes magnetic levitation components operable to control an axial position and a radial position of the rotor. The rotor is disposed in the inner blood flow conduit and includes an impeller operable to pump blood from the inlet opening to the outlet opening through at least a portion of the magnetic levitation components of the stator.


Implementations of the above aspects may include one or more of the following features. For example, the stator is disposed circumferentially about at least a part of the rotor and is positioned relative to the rotor such that in use blood flows within the blood flow conduit through the stator before reaching the rotor. The rotor has permanent magnetic poles for magnetic levitation of the rotor. A passive magnetic control system is configured to control an axial position of the rotor relative to the stator, and an active electromagnetic control system is configured to radially center the rotor within the inner blood flow conduit. An electromagnetic control system controls at least one of a radial position and an axial position of the rotor relative to the stator, and the electromagnetic control system has control electronics located within the housing about the dividing wall.


The control electronics are located between the inlet opening and the stator. The control electronics can be configured to control the active magnetic control system. The rotor has only one magnetic moment. The stator includes a first coil for driving the rotor and a second coil for controlling a radial position of the rotor, and the first coil and the second coil are wound around a first pole piece of the stator. The housing has a first face that defines the inlet opening, a second face opposing the first face, and a peripheral wall extending from the first face to the second face. The housing includes a rounded transition from the second face to the peripheral wall. The housing defines a volute located such that in use blood flows within the blood flow conduit through the stator before reaching the volute. The volute can be located between the stator and the second face. The housing can also include a cap that includes the second face, defines at least part of the volute, and defines at least part of the outlet. The cap is engaged with the peripheral wall of the housing. The housing also includes an inlet cannula extending from the first face and in fluid communication with the inlet opening. The inlet cannula can be inserted into the patient's heart. The outlet opening is defined in the second face and/or the peripheral wall. A thickness of the housing between the first face and the second face is less than a width of the housing.


In another general aspect, a method includes inserting a puck-shaped blood pump housing into a patient's body. The blood pump is inserted such that an opening defined in a first flat face of the housing that is proximate to a stator of the blood pump faces the patient's heart. Additionally, the blood pump is inserted such that a second rounded face of the housing that is proximate to an impeller of the blood pump faces away from the patient's heart. The first face is disposed against a portion of the patient's heart such that the second face of the housing faces away from the heart of the patient. In some implementations, the method includes inserting an inlet cannula of the housing into the patient's heart.


In another general aspect, making a blood pump includes assembling a motor stator and control electronics in a puck-shaped housing circumferentially about an internal dividing wall. The internal dividing wall defines an inner blood flow conduit that extends from an inlet opening to an outlet opening of the housing. The stator is assembled in the housing such that the inner blood flow conduit extends through the motor stator. Disposed within the inner blood flow conduit is a magnetically-levitated rotor. The rotor is surrounded by the stator such that impeller blades carried by the rotor are downstream of the stator from the inlet opening. In use, the impeller pumps blood from the inlet opening to the outlet opening through the stator.


Implementations may include one or more of the following features. For example, the rotor has only one magnetic moment. The stator includes at least one first coil for driving the rotor and at least one second coil for controlling a radial position of the rotor, the at least one first coil and the at least one second coil being wound around a first pole piece of the stator. The housing includes a first face that defines the inlet opening, and further comprising engaging an end cap with a peripheral wall of the housing, the end cap including a second face, defining at least part of a volute, and defining at least part of the outlet opening. The housing includes a rounded transition from the second face to the peripheral wall. The housing further includes an inlet cannula extending from the First face and in fluid communication with the inlet opening. A thickness of the housing between the first face and the second face is less than a width of the housing.


In another general aspect, a method of pumping blood includes magnetically rotating a centrifugal pump impeller of a blood pump device to draw blood from a patient's heart through an inlet opening of a housing of the blood pump device into an inner blood flow conduit within a stator in the housing, through the inner blood flow conduit, and through an outlet opening of the housing. The method includes selectively controlling a radial position of the impeller within the inner blood flow conduit.


The details of one or more implementations are set forth in the accompanying drawings and the description below. Other features will be apparent from the description and drawings, and from the claims.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is an illustration of a blood pump in a use position implanted in a patient's body.



FIG. 2 is a cross-sectional view of the blood pump of FIG. 1.



FIG. 3 is a partial cut-away perspective view of a stator of a blood pump.



FIG. 4 is a bottom perspective view of a blood pump.



FIG. 5 is a top perspective view of the blood pump of FIG. 4.



FIG. 6 is a front view of the blood pump of FIG. 4.



FIG. 7 is a back view of the blood pump of FIG. 4.



FIG. 8 is a right side view of the blood pump of FIG. 4.



FIG. 9 is a left side view of the blood pump of FIG. 4.



FIG. 10 is a bottom view of the blood pump of FIG. 4.



FIG. 11 is a top view of the blood pump of FIG.





DETAILED DESCRIPTION

With reference to FIGS. 1 and 4-11, a left ventricular assist blood pump 100 having a puck-shaped housing 110 is implanted in a patient's body with a first face 111 of the housing 110 positioned against the patient's heart H and a second face 113 of the housing 110 facing away from the heart H. The first face 111 of the housing 110 includes an inlet cannula 112 extending into the left ventricle LV of the heart H. The second face 113 of the housing 110 has a chamfered edge 114 to avoid irritating other tissue that may come into contact with the blood pump 100, such as the patient's diaphragm. To construct the illustrated shape of the puck-shaped housing 110 in a compact form, a stator 120 and electronics 130 of the pump 100 are positioned on the inflow side of the housing toward first face 111, and a rotor 140 of the pump 100 is positioned along the second face 113. This positioning of the stator 120, electronics 130, and rotor 140 permits the edge 114 to be chamfered along the contour of the rotor 140, as illustrated in at least FIGS. 2, 4, and 6-9, for example.


Referring to FIG. 2, the blood pump 100 includes a dividing wall 115 within the housing 110 defining a blood flow conduit 103. The blood flow conduit 103 extends from an inlet opening 101 of the inlet cannula 112 through the stator 120 to an outlet opening 105 defined by the housing 110. The rotor 140 is positioned within the blood flow conduit 103. The stator 120 is disposed circumferentially about a first portion 140a of the rotor 140, for example about a permanent magnet 141. The stator 120 is also positioned relative to the rotor 140 such that, in use, blood flows within the blood flow conduit 103 through the stator 120 before reaching the rotor 140. The permanent magnet 141 has a permanent magnetic north pole N and a permanent magnetic south pole S for combined active and passive magnetic levitation of the rotor 140 and for rotation of the rotor 140. The rotor 140 also has a second portion 140b that includes impeller blades 143. The impeller blades 143 are located within a volute 107 of the blood flow conduit such that the impeller blades 143 are located proximate to the second face 113 of the housing.


The puck-shaped housing 110 further includes a peripheral wall 116 that extends between the first face 111 and a removable cap 118. As illustrated, the peripheral wall 116 is formed as a hollow circular cylinder having a width W between opposing portions of the peripheral wall 116. The housing 110 also has a thickness T between the first face 111 and the second face 113 that is less than the width W. The thickness T is from about 0.5 inches to about 1.5 inches, and the width W is from about 1 inch to about 4 inches. For example, the width W can be approximately 2 inches, and the thickness T can be approximately 1 inch.


The peripheral wall 116 encloses an internal compartment 117 that surrounds the dividing wall 115 and the blood flow conduit 103, with the stator 120 and the electronics 130 disposed in the internal compartment 117 about the dividing wall 115. The removable cap 118 includes the second face 113, the chamfered edge 114, and defines the outlet opening 105. The cap 118 can be threadably engaged with the peripheral wall 116 to seal the cap 118 in engagement with the peripheral wall 116. The cap 118 includes an inner surface 118a of the cap 118 that defines the volute 107 that is in fluid communication with the outlet opening 105.


Within the internal compartment 117, the electronics 130 are positioned adjacent to the first face 111 and the stator 120 is positioned adjacent to the electronics 130 on an opposite side of the electronics 130 from the first face 111. The electronics 130 include circuit boards 131 and various components 133 carried on the circuit boards 131 to control the operation of the pump 100 by controlling the electrical supply to the stator 120. The housing 110 is configured to receive the circuit boards 131 within the internal compartment 117 generally parallel to the first face 111 for efficient use of the space within the internal compartment 117. The circuit boards also extend radially-inward towards the dividing wall 115 and radially-outward towards the peripheral wall 116. For example, the internal compartment 117 is generally sized no larger than necessary to accommodate the circuit boards 131, and space for heat dissipation, material expansion, potting materials, and/or other elements used in installing the circuit boards 131. Thus, the external shape of the housing 110 proximate the first face 111 generally fits the shape of the circuits boards 131 closely to provide external dimensions that are not much greater than the dimensions of the circuit boards 131.


With continued reference to FIG. 2 and with reference to FIG. 3, the stator 120 includes a back iron 121 and pole pieces 123a-123f arranged at intervals around the dividing wall 115. The back iron 121 extends around the dividing wall 115 and is formed as a generally flat disc of a ferromagnetic material, such as steel, in order to conduct magnetic flux. The back iron 121 is arranged beside the control electronics 130 and provides a base for the pole pieces 123a-123f.


Each of the pole piece 123a-123f is L-shaped and has a drive coil 125 for generating an electromagnetic field to rotate the rotor 140. For example, the pole piece 123a has a first leg 124a that contacts the back iron 121 and extends from the back iron 121 towards the second face 113. The pole piece 123a also has a second leg 124b that extends from the first leg 124a towards the dividing wall 115 proximate the location of the permanent magnet 141 of the rotor 140. Each of the pole pieces 123a-123f also has a levitation coil 127 for generating an electromagnetic field to control the radial position of the rotor 140.


Each of the drive coils 125 and the levitation coils 127 includes multiple windings of a conductor around the pole pieces 123a-123f. Particularly, each of the drive coils 125 is wound around two adjacent ones of the pole pieces 123, such as pole pieces 123d and 123e, and each levitation coil 127 is wound around a single pole piece. The drive coils 125 and the levitation coils 127 are wound around the first legs of the pole pieces 123, and magnetic flux generated by passing electrical current though the coils 125 and 127 during use is conducted through the first legs and the second legs of the pole pieces 123 and the back iron 121. The drive coils 125 and the levitation coils 127 of the stator 120 are arranged in opposing pairs and are controlled to drive the rotor and to radially levitate the rotor 140 by generating electromagnetic fields that interact with the permanent magnetic poles S and N of the permanent magnet 141. Because the stator 120 includes both the drive coils 125 and the levitation coils 127, only a single stator is needed to levitate the rotor 140 using only passive and active magnetic forces. The permanent magnet 141 in this configuration has only one magnetic moment and is formed from a monolithic permanent magnetic body 141. For example, the stator 120 can be controlled as discussed in U.S. Pat. No. 6,351,048, the entire contents of which are incorporated herein by reference. The control electronics 130 and the stator 120 receive electrical power from a remote power supply via a cable 119 (FIG. 1).


The rotor 140 is arranged within the housing 110 such that its permanent magnet 41 is located upstream of impeller blades in a location closer to the inlet opening 101. The permanent magnet 141 is received within the blood flow conduit 103 proximate the second legs 124b of the pole pieces 123 to provide the passive axial centering force though interaction of the permanent magnet 141 and ferromagnetic material of the pole pieces 123. The permanent magnet 141 of the rotor 140 and the dividing wall 115 form a gap 108 between the permanent magnet 141 and the dividing wall 115 when the rotor 140 is centered within the dividing wall 115. The gap 108 may be from about 0.2 millimeters to about 2 millimeters. For example, the gap 108 is approximately 1 millimeter. The north permanent magnetic pole N and the south permanent magnetic pole S of the permanent magnet 141 provide a permanent magnetic attractive force between the rotor 140 and the stator 120 that acts as a passive axial centering force that tends to maintain the rotor 140 generally centered within the stator 120 and tends to resist the rotor 140 from moving towards the first face 111 or towards the second face 113. When the gap 108 is smaller, the magnetic attractive force between the permanent magnet 141 and the stator 120 is greater, and the gap 108 is sized to allow the permanent magnet 141 to provide the passive magnetic axial centering force having a magnitude that is adequate to limit the rotor 140 from contacting the dividing wall 115 or the inner surface 118a of the cap 118. The rotor 140 also includes a shroud 145 that covers the ends of the impeller blades 143 facing the second face 113 that assists in directing blood flow into the volute 107. The shroud 145 and the inner surface 118a of the cap 118 form a gap 109 between the shroud 145 and the inner surface 118a when the rotor 140 is levitated by the stator 120. The gap 109 is from about 0.2 millimeters to about 2 millimeters. For example, the gap 109 is approximately 1 millimeter.


As blood flows through the blood flow conduit 103, blood flows through a central aperture 141 a formed through the permanent magnet 141. Blood also flows through the gap 108 between the rotor 140 and the dividing wall 115 and through the gap 109 between the shroud 145 and the inner surface 108a of the cap 118. The gaps 108 and 109 are large enough to allow adequate blood flow to limit clot formation that may occur if the blood is allowed to become stagnant. The gaps 108 and 109 are also large enough to limit pressure forces on the blood cells such that the blood is not damaged when flowing through the pump 100. As a result of the size of the gaps 108 and 109 limiting pressure forces on the blood cells, the gaps 108 and 109 are too large to provide a meaningful hydrodynamic suspension effect. That is to say, the blood does not act as a bearing within the gaps 108 and 109, and the rotor is only magnetically-levitated.


Because the rotor 140 is radially suspended by active control of the levitation coils 127 as discussed above, and because the rotor 140 is axially suspended by passive interaction of the permanent magnet 141 and the stator 120, no rotor levitation components are needed proximate the second face 113. The incorporation of all the components for rotor levitation in the stator 120 (i.e., the levitation coils 127 and the pole pieces 123) allows the cap 118 to be contoured to the shape of the impeller blades 143 and the volute 107. Additionally, incorporation of all the rotor levitation components in the stator 120 eliminates the need for electrical connectors extending from the compartment 117 to the cap 118, which allows the cap to be easily installed and/or removed and eliminates potential sources of pump failure.


In use, the drive coils 125 of the stator 120 generates electromagnetic fields through the pole pieces 123 that selectively attract and repel the magnetic north pole N and the magnetic south pole S of the rotor 140 to cause the rotor 140 to rotate within stator 120. As the rotor 140 rotates, the impeller blades 143 force blood into the volute 107 such that blood is forced out of the outlet opening 105. Additionally, the rotor draws blood into pump 100 through the inlet opening 101. As blood is drawn into the blood pump by rotation of the impeller blades 143 of the rotor 140, the blood flows through the inlet opening 101 and flows through the control electronics 130 and the stator 120 toward the rotor 140. Blood flows through the aperture 141a of the permanent magnet 141 and between the impeller blades 143, the shroud 145, and the permanent magnet 141, and into the volute 107. Blood also flows around the rotor 140, through the gap 108 and through the gap 109 between the shroud 145 and the inner surface 118a of the cap 118. The blood exits the volute 107 through the outlet opening 105.


A number of implementations have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the claimed invention. For example, the cap 118 can be engaged with the peripheral wall 116 using a different attachment mechanism or technique, including snap-fit engagement, adhesives, or welding. Additionally, while the cap 118 has been described as defining the outlet opening 105 and the chamfered edge 114, the outlet opening 105 and/or the chamfered edge 114 can be defined by the peripheral wall 116 or by both the peripheral wall 116 and the cap 118. Similarly, the dividing wall 115 can be formed as part of the cap 118.


Additionally, the rotor 140 can include two or more permanent magnets. The number and configuration of the pole pieces 123 can also be varied. The operation of the control electronics 130 is selected to account for the number and position of pole pieces of the stator and permanent magnets of the rotor. Also, the cap 118 can be engaged with the peripheral wall using other techniques, such as adhesives, welding, snap-fit, shrink-fit, or other technique or structure.


Similarly, the first face 111 may be formed from a separate piece of material than the peripheral wall 116 and the first face 111, including the inlet cannula 112, can be attached to the peripheral wall 116, such as by welding, after the control electronics 130 and the stator 120 have been mounted in the internal compartment 117. The shroud 145 may be omitted and optionally replaced by other flow control devices to achieve a desired pump efficiency. As another option, the control electronics 130 can be located external to the pump 100, such as in a separate housing implanted in the patient's abdomen, or external to the patient's body.


In some implementations, the dimensions of the housing 110 can be larger or smaller than those described above. Similarly, the ratio of the width W of the housing 110 to the thickness T of the housing can be different than the ratio described above. For example, the width W can be from about 1.1 to about 5 times greater than the thickness T. Additionally, the permanent magnet 141 of the rotor 140 can include two or more pairs of north and south magnetic poles. While the peripheral wall 116 and the dividing wall 115 are illustrated as cylinders having circular cross-sectional shapes, one or both can alternatively be formed having other cross-sectional shapes, such as oval, or an irregular shape. Similarly, the peripheral wall 116 can be tapered such that the housing does not have a constant width W from the first face 111 the second face 113.


As mentioned above, in some implementations, the blood pump 100 can be used to assist a patient's heart during a transition period, such as during a recovery from illness and/or surgery or other treatment. In other implementations, the blood pump 100 can be used to partially or completely replace the function of the patient's heart on a generally permanent basis, such as where the patient's aortic valve is surgically sealed.


Accordingly, other embodiments are within the scope of the following claims.

Claims
  • 1. A method for assisting blood circulation in a patient, the method comprising: drawing a flow of blood from a patient's heart into a blood flow channel formed by a housing;passing the flow of blood through a motor stator disposed within the housing and to a rotor disposed within the blood flow channel, the motor stator comprising a plurality of stator poles arranged circumferentially around the blood flow channel, the rotor having a rotor axis of rotation and including at least one rotor magnet for rotation and levitation of the rotor within the blood flow channel;controlling delivery of current to a plurality of drive coils to generate electromagnetic fields to interact with the at least one rotor magnet to rotate the rotor to pump blood through the blood flow channel, each of the drive coils being wound around a respective one of the plurality of stator poles, each of the stator poles axially overlapping with the at least one rotor magnet in the direction of the rotor axis of rotation;controlling delivery of current to a plurality of levitation coils to generate electromagnetic fields to interact with the at least one rotor magnet to control a radial position of the rotor within the blood flow channel transverse to the rotor axis of rotation, each of the levitation coils being wound around a respective one or more of the plurality of stator poles;levitating the rotor within the blood flow channel in the direction of the rotor axis of rotation via a passive magnetic interaction between the at least one rotor magnet and ferromagnetic material of the plurality of stator poles; andoutputting the flow of blood from the blood flow channel to the patient.
  • 2. The method of claim 1, further comprising supporting the plurality of pole pieces via a back iron configured to conduct magnetic flux and having an aperture through which the blood flow channel passes.
  • 3. The method of claim 2, further comprising supporting control electronics within the housing and between the back iron and the patient's heart, the control electronics being configured to control the delivery of current to the plurality of drive coils and to control the delivery of current to the plurality of levitation coils.
  • 4. The method of claim 1, wherein the plurality of drive coils are arranged in opposing pairs in which the drive coils in each opposing pair of the plurality of drive coils is disposed on opposite sides of the blood flow channel.
  • 5. The method of claim 1, wherein: each of the plurality of levitation coils is wound around two adjacent stator poles of the plurality of stator poles; andthe plurality of levitation coils are arranged in opposing pairs in which the levitation coils in each opposing pair of the plurality of levitation coils is disposed on opposite sides of the blood flow channel.
  • 6. The method of claim 1, wherein the at least one rotor magnet comprises a permanent magnet, the method further comprising: passing a first portion of the flow of blood through a central aperture formed through the permanent magnet; andpassing a second portion of the flow of blood through a radial gap formed between the rotor and the housing perpendicular to the rotor axis of rotation.
  • 7. The method of claim 6, wherein the rotor and housing are configured and the delivery of current to the plurality of levitation coils is controlled such that the radial gap between the rotor and the housing is between about 0.2 mm to about 2 mm.
  • 8. The method of claim 6, comprising impelling the first portion of the flow of blood via impeller blades of the rotor to force the flow of blood from the blood flow channel to the artery of the patient.
  • 9. The method of claim 8, wherein: the first portion of the flow of blood is impelled substantially centrifugally via the rotor; andthe flow of blood is output from the blood flow channel in a direction transverse to the rotor axis of rotation.
  • 10. The method of claim 1, wherein the flow of blood is output from the blood flow channel at a substantially 90 degree angle relative to a direction in which the flow of blood is drawn into the blood flow channel.
  • 11. The method of claim 1, wherein the rotor is levitated within the blood flow channel in the direction of the rotor axis of rotation such that the rotor is separated from the housing in the direction of the rotor axis of rotation via axial gaps between about 0.2 mm to about 2 mm.
  • 12. The method of claim 1, wherein the flow of blood passes completely through the motor stator.
CROSS-REFERENCES TO RELATED APPLICATIONS

This application is a continuation application of U.S. application Ser. No. 13/212,813, filed Aug. 18, 2011, now Issued U.S. Pat. No. 9,091,271, issued Jul. 28, 2015, and titled “Implantable Blood Pump,” which application claims the benefit of U.S. Provisional Application Ser. No. 61/375,504, filed Aug. 20, 2010, and titled “Implantable Blood Pump,” the entire contents of which are incorporated herein by reference in their entirety.

US Referenced Citations (167)
Number Name Date Kind
845816 Prindle Mar 1907 A
888654 Prindle May 1908 A
1026101 Marsh May 1912 A
2128988 Christian Sep 1938 A
2747512 Fouche May 1956 A
2864552 Anderson et al. Dec 1958 A
3005117 Buchhold Oct 1961 A
3066849 Beams et al. Dec 1962 A
3122101 Baker et al. Feb 1964 A
3225608 Simon et al. Dec 1965 A
3401640 Fowler et al. Sep 1968 A
3499274 Fergason Mar 1970 A
3575536 Jacobs et al. Apr 1971 A
3597022 Waldron Aug 1971 A
3608088 Dorman et al. Sep 1971 A
3611815 Fischell et al. Oct 1971 A
3647324 Rafferty et al. Mar 1972 A
3650581 Boden et al. Mar 1972 A
3938913 Isenberg et al. Feb 1976 A
3957389 Rafferty et al. May 1976 A
4082376 Wehde et al. Apr 1978 A
4135253 Reich et al. Jan 1979 A
4213207 Wilson et al. Jul 1980 A
4340260 Forster et al. Jul 1982 A
4382199 Isaacson May 1983 A
4398773 Boden et al. Aug 1983 A
4405286 Studer Sep 1983 A
4408966 Maruyama et al. Oct 1983 A
4475866 Kambe et al. Oct 1984 A
4507048 Belenger et al. Mar 1985 A
4589822 Clausen et al. May 1986 A
4642036 Young et al. Feb 1987 A
4688998 Olsen et al. Aug 1987 A
4704121 Moise et al. Nov 1987 A
4763032 Bramm et al. Aug 1988 A
4779614 Moise Oct 1988 A
4844707 Kletschka et al. Jul 1989 A
4876492 Lester et al. Oct 1989 A
4878831 Ewing et al. Nov 1989 A
4929158 Girault May 1990 A
4944748 Bramm et al. Jul 1990 A
4957504 Chardack Sep 1990 A
5055005 Kletschka et al. Oct 1991 A
5078741 Bramm et al. Jan 1992 A
5106273 Lemarquand et al. Apr 1992 A
5112200 Isaacson et al. May 1992 A
5112202 Oshima et al. May 1992 A
5126612 Girault Jun 1992 A
5127792 Katsuta et al. Jul 1992 A
5159219 Chu et al. Oct 1992 A
5177387 McMichael et al. Jan 1993 A
5195877 Kletschka Mar 1993 A
5220232 Rigney, II et al. Jun 1993 A
5341059 Fujimoto et al. Aug 1994 A
5385581 Bramm et al. Jan 1995 A
5470208 Kletschka Nov 1995 A
5708346 Schoeb Jan 1998 A
5725357 Nakazeki et al. Mar 1998 A
5798454 Nakazeki et al. Aug 1998 A
5808437 Schoeb Sep 1998 A
5917297 Gerster et al. Jun 1999 A
5928131 Prem Jul 1999 A
5947703 Nojiri et al. Sep 1999 A
6053705 Schoeb et al. Apr 2000 A
6100618 Schoeb et al. Aug 2000 A
6130494 Schoeb Oct 2000 A
6146325 Lewis et al. Nov 2000 A
6222290 Schöb et al. Apr 2001 B1
6227797 Watterson et al. May 2001 B1
6234772 Wampler et al. May 2001 B1
6249067 Schob et al. Jun 2001 B1
6264635 Wampler et al. Jul 2001 B1
6278251 Schöb et al. Aug 2001 B1
6293901 Prem Sep 2001 B1
6302661 Khanwilkar et al. Oct 2001 B1
6351048 Schob et al. Feb 2002 B1
6355998 Schöb et al. Mar 2002 B1
6394769 Bearnson et al. May 2002 B1
6447266 Antaki et al. Sep 2002 B2
6468041 Ozaki Oct 2002 B2
6559567 Schöb May 2003 B2
6575717 Ozaki et al. Jun 2003 B2
6589030 Ozaki Jul 2003 B2
6605032 Benkowski et al. Aug 2003 B2
6623475 Siess Sep 2003 B1
6626644 Ozaki Sep 2003 B2
6634224 Schöb et al. Oct 2003 B1
6640617 Schöb et al. Nov 2003 B2
6641378 Davis et al. Nov 2003 B2
6688861 Wampler Feb 2004 B2
6707200 Carroll et al. Mar 2004 B2
6711943 Schöb et al. Mar 2004 B1
6817836 Nose et al. Nov 2004 B2
6949066 Bearnson et al. Sep 2005 B2
7070398 Li et al. Jul 2006 B2
7112903 Schob Sep 2006 B1
7138776 Gauthier et al. Nov 2006 B1
7150711 Nüsser et al. Dec 2006 B2
D534548 Urano et al. Jan 2007 S
7160242 Yanai Jan 2007 B2
7229258 Wood et al. Jun 2007 B2
7229474 Hoffmann et al. Jun 2007 B2
7239098 Masino Jul 2007 B2
7284956 Nose et al. Oct 2007 B2
7338521 Antaki et al. Mar 2008 B2
7462019 Olsen et al. Dec 2008 B1
7497116 Miyakoshi et al. Mar 2009 B2
7511443 Townsend et al. Mar 2009 B2
7578782 Miles et al. Aug 2009 B2
7591777 LaRose et al. Sep 2009 B2
7645225 Medvedev et al. Jan 2010 B2
7699588 Mendler Apr 2010 B2
7854631 Townsendl et al. Dec 2010 B2
7861582 Miyakoshi et al. Jan 2011 B2
7887479 LaRose et al. Feb 2011 B2
7951062 Morello May 2011 B2
7976271 LaRose et al. Jul 2011 B2
8152493 Thyagarajan et al. Apr 2012 B2
8157720 Marseille et al. Apr 2012 B2
8303482 Schima et al. Nov 2012 B2
8382830 Maher et al. Feb 2013 B2
8506470 LaRose et al. Aug 2013 B2
8517699 Horvath Aug 2013 B2
8556795 Bolyard et al. Oct 2013 B2
8597350 Rudser et al. Dec 2013 B2
8764621 Badstibner et al. Jul 2014 B2
8870739 LaRose et al. Oct 2014 B2
8882477 Fritz, IV et al. Nov 2014 B2
8956275 Bolyard et al. Feb 2015 B2
20030021683 Capone et al. Jan 2003 A1
20040236420 Yamane et al. Nov 2004 A1
20050004421 Pacella et al. Jan 2005 A1
20050025630 Ayre et al. Feb 2005 A1
20050147512 Chen et al. Jul 2005 A1
20070100196 LaRose May 2007 A1
20090064755 Fleischli et al. Mar 2009 A1
20090234447 LaRose et al. Sep 2009 A1
20100130809 Morello May 2010 A1
20100150749 Horvath et al. Jun 2010 A1
20100152526 Pacella et al. Jun 2010 A1
20100241223 Lee et al. Sep 2010 A1
20100327687 Iannello et al. Dec 2010 A1
20110002794 Haefliger et al. Jan 2011 A1
20110031836 Nussbaumer Feb 2011 A1
20110054239 Sutton et al. Mar 2011 A1
20110071337 Thompson et al. Mar 2011 A1
20110144413 Foster et al. Jun 2011 A1
20110187217 Nussbaumer Aug 2011 A1
20110237863 Ricci Sep 2011 A1
20110245582 Zafirelis et al. Oct 2011 A1
20110313237 Miyakoshi et al. Dec 2011 A1
20120035411 LaRose et al. Feb 2012 A1
20120046514 Bourque Feb 2012 A1
20120059212 LaRose et al. Mar 2012 A1
20120134832 Wu et al. May 2012 A1
20120226097 Smith et al. Sep 2012 A1
20120245680 Masuzawa Sep 2012 A1
20120245681 Casas et al. Sep 2012 A1
20120253103 Robert et al. Oct 2012 A1
20120310036 Peters et al. Dec 2012 A1
20130331934 Kabir et al. Dec 2013 A1
20140100413 Casas et al. Apr 2014 A1
20140194985 Vadala, Jr. Jul 2014 A1
20140275723 Fritz, IV et al. Sep 2014 A1
20140303426 Kerkhoffs et al. Oct 2014 A1
20140357937 Reyes et al. Dec 2014 A1
20150051438 Taskin Feb 2015 A1
Foreign Referenced Citations (21)
Number Date Country
300837668 Oct 2008 CN
150320 May 1990 EP
60569 Dec 1990 EP
378251 Jun 1994 EP
2357374 Aug 2011 EP
1491710 Nov 1977 GB
01257792 Oct 1989 JP
02016390 Jan 1990 JP
03088996 Apr 1991 JP
04148095 May 1992 JP
2000510929 Aug 2000 JP
2002512333 Apr 2002 JP
2003093500 Apr 2003 JP
D1373017 Oct 2009 JP
2011530315 Dec 2011 JP
D136032 Jul 2010 TW
9953974 Oct 1999 WO
2006137496 Dec 2006 WO
2010015836 Feb 2010 WO
2010036815 Jun 2010 WO
2012028181 Mar 2012 WO
Non-Patent Literature Citations (5)
Entry
Barletta et al., “Design of a bearing less blood pump”, Proc.3rd Int. Symp. on Magnetic Suspension Technology, Dec. 13-15, 1995, pp. 265-274.
PCT/US2011/048259 , “International Preliminary Report on Patentability”, Mar. 7, 2013, 9 pages.
PCT/US2011/048259 , “International Search Report and Written Opinion”, Dec. 20, 2011, 13 pages.
Antaki et al., “PediaFlowTM Maglev Ventricular Assist Device: A Prescriptive Design Approach”, Cardiovascular Engineering and Technology, vol. 1, No. 1 (Mar. 2010), 104-121.
Izraelev et al., “A Paaively-Suspended Tesla Pump Left Ventricular Assist Device”, NIH Public Access, vol. 55, No. 6 (2009), pp. 556-561.
Related Publications (1)
Number Date Country
20150273125 A1 Oct 2015 US
Provisional Applications (1)
Number Date Country
61375504 Aug 2010 US
Continuations (1)
Number Date Country
Parent 13212813 Aug 2011 US
Child 14735990 US